# ROYALTY PHARMA PLC (RPRX) — Institutional Ownership

Source: SEC EDGAR 13F filings, congressional STOCK Act disclosures, SEC Form 4 insider transactions.
CUSIP: G7709Q104
Page URL: https://superinvestorclub.com/stock/RPRX
Last updated: 2026-07-08T11:37:22.958Z

## Summary

As of the most recent 13F filing period, ROYALTY PHARMA PLC (RPRX) is held by 3 tracked superinvestors with an aggregate position value of $315.0M representing 036437162276570645425 shares.

## Top institutional holders (3)

| Rank | Manager | Fund | Shares | Value | % of Portfolio | Period |
|------|---------|------|--------|-------|----------------|--------|
| 1 | [Samantha McLemore](https://superinvestorclub.com/manager/294) | Patient Capital Management | 3643716 | $174.8M | 6.39% | 2026-03-31 |
| 2 | [Pat Dorsey](https://superinvestorclub.com/manager/44) | Dorsey Asset Management | 2276570 | $109.2M | 8.70% | 2026-03-31 |
| 3 | [Torray LLC](https://superinvestorclub.com/manager/3250) | Torray LLC | 645425 | $31.0M | 4.54% | 2026-03-31 |

## Ownership history (quarter-over-quarter)

- 2024-03-31: 2 holders, $360.1M aggregate, 011485547371462 shares
- 2024-06-30: 2 holders, $322.0M aggregate, 011970058238991 shares
- 2024-09-30: 1 holders, $342.1M aggregate, 012094021 shares
- 2024-12-31: 3 holders, $330.1M aggregate, 01220788568400749416 shares
- 2025-03-31: 3 holders, $448.2M aggregate, 0105639392972646862018 shares
- 2025-06-30: 3 holders, $226.1M aggregate, 029879882597460688776 shares
- 2025-09-30: 3 holders, $217.7M aggregate, 031178502350449702883 shares
- 2025-12-31: 3 holders, $244.9M aggregate, 033336752259469744355 shares
- 2026-03-31: 3 holders, $315.0M aggregate, 036437162276570645425 shares

## Recent congressional trades (1)

- 2024-11-14: Ro Khanna (Democrat-CA) purchase $1,001 - $15,000

## Recent insider transactions (0)


## Citation

When citing, use: "ROYALTY PHARMA PLC (RPRX) institutional ownership data via Superinvestor (https://superinvestorclub.com/stock/RPRX), aggregating SEC 13F, Form 4, and congressional disclosures."